Issue 5, 2015

Targeted labeling of an early-stage tumor spheroid in a chorioallantoic membrane model with upconversion nanoparticles

Abstract

In vivo detection of cancer at an early-stage, i.e. smaller than 2 mm, is a challenge in biomedicine. In this work target labeling of an early-stage tumor spheroid (∼500 μm) is realized for the first time in a chick embryo chorioallantoic membrane (CAM) model with monoclonal antibody functionalized upconversion nanoparticles (UCNPs-mAb).

Graphical abstract: Targeted labeling of an early-stage tumor spheroid in a chorioallantoic membrane model with upconversion nanoparticles

Supplementary files

Article information

Article type
Communication
Submitted
26 Sep 2014
Accepted
26 Oct 2014
First published
03 Nov 2014

Nanoscale, 2015,7, 1596-1600

Author version available

Targeted labeling of an early-stage tumor spheroid in a chorioallantoic membrane model with upconversion nanoparticles

K. Liu, J. A. Holz, Y. Ding, X. Liu, Y. Zhang, L. Tu, X. Kong, B. Priem, A. Nadort, S. A. G. Lambrechts, M. C. G. Aalders, W. J. Buma, Y. Liu and H. Zhang, Nanoscale, 2015, 7, 1596 DOI: 10.1039/C4NR05638H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements